The MedCan 2022 Industry Summit will help local companies accelerate their path to market through valuable insights into exporting, innovation and education. Industry experts will be presenting the latest scientific findings and breakthrough technologies and exploring the current challenges and opportunities around the likes of cultivating, manufacturing, New Zealand regulations, export, clinical trials, prescription and investment.
Day 1 – Industry Summit – 10 February
11:30
Science
Novel anticonvulsant phytocannabinoids, pharmacokinetic entourage, and effects of CBN on sleep Associate Professor Jonathan Arnold Deputy Academic Director, Sydney Pharmacy School Lambert Initiative for Cannabinoid Therapeutics
12:00
Science
Digging for seeds | Opportunities to run an internationally competitive structured breeding programme for New Zealand
• New Zealand gene bank
• different genetic technologies
• development of unique plants to those grown internationally
• Which traits to select- from disease resistance to cannabinoid profiles
• role of data management in a well-run breeding programme
Dr Anna Campbell Consultant, AbacusBio
12:30
Science
Understand the diseases that threaten NZ’s medicinal cannabis industry Kai Keli’iho’omalu Cultivation Manager, Helius Therapeutics
14:00
Science
Growth in cannabis testing | Where is New Zealand at on this front? - Highlighting the different services available in cannabis testing in New Zealand
- How does New Zealand rank globally on testing?
- Providing a global view – what are the trends we are seeing in cannabis testing around the world?
- Any key learnings for New Zealand to implement?
14:30
Science
Challenges running and supplying clinical trials – Industry and academic experiences - Making the business case for commercialising medicinal cannabis whilst adhering to the regulations – how can this be achieved effectively?
- Understanding methodological innovations required when undertaking Research on cannabis
Dr. Adele Hosseini, PhD Chief Scientific Officer, Bod Australia
15:00
Science
Moving forward – an overview of the current clinical trials space, producing the evidence needed for product registration in Australia Dr Rachel Galettis Clinical Trial Manager, Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE)